High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non‐small cell lung cancer

BACKGROUND: The treatment efficacy of immune checkpoint inhibitor (ICI) and clinical outcomes in patients with non‐small cell lung cancer (NSCLC) who develop severe grade checkpoint inhibitor pneumonitis (CIP) are unclear. Here, we report on the treatment efficacy of ICI and prognosis in NSCLC patie...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thorac Cancer
Autors principals: Tone, Mari, Izumo, Takehiro, Awano, Nobuyasu, Kuse, Naoyuki, Inomata, Minoru, Jo, Tatsunori, Yoshimura, Hanako, Minami, Jonsu, Takada, Kohei, Miyamoto, Shingo, Kunitoh, Hideo
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons Australia, Ltd 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6775002/
https://ncbi.nlm.nih.gov/pubmed/31482678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13187
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars